Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

25 Apr 2016 07:00

RNS Number : 1379W
Immunodiagnostic Systems Hldgs PLC
25 April 2016
 



 

 

 

 

Full year trading update

 

Immunodiagnostic Systems Holdings PLC

25 April 2016

 

 

 

 

 

 

25 April 2016

 

Immunodiagnostic Systems Holdings plc Trading Update for year ended 31 March 2016

 

Immunodiagnostic Systems Holdings plc ("the Group"), a specialist solution provider to the clinical laboratory diagnostic market, today provides a trading update for the year ended 31 March 2016.

 

Total revenues are expected to be c. £39 million (2015: £45 million), in line with the guidance given in November 2015. The decrease in revenues year on year is mainly due to further reductions in our manual assay business, where test volumes continue to migrate to automated solutions offered by us and others. In addition, we are continuing to lose automated 25-OH Vitamin D business as the larger laboratories migrate test volumes previously run on the iSYS analyzer to workhorses (i.e. high-throughput analyzers) when their contracts with IDS come due for renewal. These revenue trends are expected to continue into the current financial year.

 

Gross direct instrument placements were 31 (2015: 54) with 43 instruments returned in the year (2015: 40), meaning net direct instrument returns were 12 (2015: net additions of 14). The total number of instruments sold to or placed with distributors or OEM partners (net) during the year was 35 (2015: 49).

 

Closing cash and cash equivalents were £26.6 million at 31 March 2016 (31 March 2015: £23.7 million; 30 September 2015: £23.5million).

At the end of the year the company employed 315 people on a full time employment basis (FY 2015:346).

We are expecting a significant asset write-down of goodwill and capitalized costs in the year ended 31 March 2016 accounts. This write down will not impact the Group's cashflow.

 

Preliminary results for the year ended 31 March 2016 will be announced on 22 June 2016.

 

For further information:

 

Immunodiagnostic Systems Holdings plc Tel : +44 (0)191 5190660

Patricio Lacalle, Chief Executive Officer

Paul Martin, Group Finance Director

 

 

Peel Hunt LLP Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDSEIFFIR
Date   Source Headline
29th Oct 20077:00 amRNSNotice of Results
5th Oct 200712:11 pmRNSNotifiable Interest
2nd Oct 20077:01 amRNSSenior Management Appointment
17th Sep 20073:33 pmRNSNotifiable Interest
17th Sep 20077:01 amRNSBoard Appointment
10th Sep 20073:48 pmRNSNotifiable Interest
3rd Sep 20077:01 amRNSTotal Voting Rights
3rd Sep 20077:00 amRNSCompletion of Acquisition
31st Aug 20073:16 pmRNSAGM Statement
28th Aug 20071:48 pmRNSResult of EGM
20th Aug 200712:36 pmRNSNotifiable Interest
20th Aug 20079:53 amRNSAIM Rule 26
3rd Aug 20077:00 amRNSProposed Acquisition
31st Jul 200711:03 amRNSTotal Voting Rights
26th Jul 20077:01 amRNSCompletion of acquisition
16th Jul 20075:57 pmRNSCorrection re. dividend dates
16th Jul 20077:01 amRNSFinal Results
29th Jun 20077:01 amRNSNotice of Results
18th Jun 20077:02 amRNSImmunoassay kits agreement
8th May 20077:01 amRNSNotifiable Interest
3rd May 20073:39 pmRNSDirectors Dealing
21st Mar 20077:00 amRNSTrading Statement
20th Mar 20075:33 pmRNSNotifiable Interest
13th Mar 20077:00 amRNSBoard Appointment
12th Feb 20077:02 amRNSBoard Appointment
31st Jan 20077:02 amRNSProduct launch
4th Jan 20077:00 amRNSProduct Launch
21st Dec 200612:48 pmRNSTotal Voting Rights
5th Dec 20069:44 amRNSDirector/PDMR Shareholding
4th Dec 20067:02 amRNSAutomation agreement
15th Nov 20068:54 amRNSHolding(s) in Company
6th Nov 20067:01 amRNSInterim Results
19th Oct 200611:34 amRNSNotice of Results
10th Oct 20067:02 amRNSIDS launches into Austria
13th Sep 20067:00 amRNSLaunch of new assay kit
22nd Aug 200611:04 amRNSAGM Statement
17th Jul 20064:35 pmRNSHolding(s) in Company
5th Jul 20067:00 amRNSFinal Results
30th May 20067:03 amRNSMarketing & sales agreement
15th May 20067:01 amRNSDirectorate Change
12th Apr 20067:01 amRNSDirector/PDMR Shareholding
30th Mar 20067:01 amRNSPre-close Trading update
21st Feb 20062:38 pmRNSDirectors Dealing
7th Nov 20057:00 amRNSInterim Results
26th Oct 20059:52 amRNSNotice of Results
26th Sep 20057:01 amRNSBoard Appointment
6th Sep 200511:18 amRNSAGM Statement
12th Aug 200510:42 amRNSFDA Approval
12th Jul 20057:01 amRNSFinal Results
6th Jul 20053:19 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.